Analysts at Piper Sandler raised their rating on Teva Pharmaceutical (TEVA) to Overweight from Neutral. They also boosted the price target to $19 from $12. The firm lists several reasons for the upgrade, including an improved outlook on the company's capital structure and the strength of its neuroscience business. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.
Analysts at Piper Sandler raised their rating on Teva Pharmaceutical (TEVA) to Overweight from Neutral. They also boosted the price target to $19 from $12. The firm lists several reasons for the upgrade, including an improved outlook on the company's capital structure and the strength of its neuroscience business.
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Editor's note: This article was written by Stephanie Mikulich.
The Wall Street Journal
0858 ET – Equinor capital distributions are expected to remain at lofty levels in 2024-2025 before normalising in 2026, but concerns on offshore wind profitability and rising renewables capex weighs on sentiment, HSBC analyst Kim Fustier writes. Green spending is set to rise from a low base to 25%-30% of total capex by 2030 and concerns around offshore wind’s profitability remain top of mind, HSBC says. HSBC retains its hold rating on Equinor and lowers its target price to NOK315 from NOK350.
The Wall Street Journal
Wall Street is convinced that [interest rates are coming down](https://www.wsj.com/finance/investing/investors-fed-interest-rates-a842073c)—and now long-term bonds are in high demand. Here's what BofA analysts are seeing in the data: + Algorithmic hedge funds that trade based on momentum are likely the most long on bonds (wagering prices will rise and yields will fall) than they've been since the first half of last year. + Speculative investors, excluding hedge funds, are betting on bonds at one of the highest rates in the past five years.